Concord Biotech has announced a final dividend of ₹10.70 per share. The ex-date for this dividend is due tomorrow, September 3, 2025. This makes today the last day to trade the stock before it turns ex-dividend; those investors who hold the shares today will be eligible to receive the dividend.
The company's last traded price was Rs 1,685.90 as of Monday's close, reflecting a 0.25% increase compared to the previous day. The company has a market capitalization of approximately 17,637.24 Crore.
Here are the key details regarding the dividend announcement:
| Particulars | Details |
|---|---|
| Dividend per share | ₹10.70 |
| Ex-Date | September 3, 2025 |
A review of Concord Biotech's recent financial performance reveals the following quarterly data. All figures are consolidated. The net profit for the quarter ending June 2025 stood at ₹42 crore. The Earnings Per Share (EPS) for the same period was ₹4.21. Comparatively, the net profit for the quarter ending March 2025 was ₹141 crore with an EPS of ₹13.42.
Additionally, the company's quarterly income statement provides further insights into its financial activities. The total income for the quarter ending June 2025 was ₹10 crore, with total expenditure at ₹86 crore. The Profit Before Tax (PBT) was ₹78 crore, and the net profit was ₹58 crore.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.